Cardinal Health Stock Fundamentals
| CLH Stock | EUR 114.60 0.50 0.44% |
CARDINAL HEALTH fundamentals help investors to digest information that contributes to CARDINAL HEALTH's financial success or failures. It also enables traders to predict the movement of CARDINAL Stock. The fundamental analysis module provides a way to measure CARDINAL HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CARDINAL HEALTH stock.
CARDINAL |
CARDINAL HEALTH Company Revenue Analysis
CARDINAL HEALTH's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current CARDINAL HEALTH Revenue | 181.36 B |
Most of CARDINAL HEALTH's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CARDINAL HEALTH is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, CARDINAL HEALTH reported 181.36 B of revenue. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The revenue for all Germany stocks is notably lower than that of the firm.
CARDINAL HEALTH Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CARDINAL HEALTH's current stock value. Our valuation model uses many indicators to compare CARDINAL HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CARDINAL HEALTH competition to find correlations between indicators driving CARDINAL HEALTH's intrinsic value. More Info.CARDINAL HEALTH is the top company in current valuation category among its peers. It also is number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for CARDINAL HEALTH is about 1,251,018,347 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CARDINAL HEALTH's earnings, one of the primary drivers of an investment's value.CARDINAL Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CARDINAL HEALTH's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CARDINAL HEALTH could also be used in its relative valuation, which is a method of valuing CARDINAL HEALTH by comparing valuation metrics of similar companies.CARDINAL HEALTH is currently under evaluation in revenue category among its peers.
CARDINAL Fundamentals
| Current Valuation | 20.94 B | |||
| Price To Book | 16.74 X | |||
| Price To Sales | 0.12 X | |||
| Revenue | 181.36 B | |||
| EBITDA | 72 M | |||
| Net Income | (933 M) | |||
| Total Debt | 4.74 B | |||
| Cash Flow From Operations | 3.12 B | |||
| Price To Earnings To Growth | 0.65 X | |||
| Market Capitalization | 12.1 B | |||
| Total Asset | 43.88 B | |||
| Z Score | 5.2 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 43.88 B | |||
| Last Dividend Paid | 0.48 |
About CARDINAL HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CARDINAL HEALTH's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CARDINAL HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CARDINAL HEALTH based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CARDINAL Stock Analysis
When running CARDINAL HEALTH's price analysis, check to measure CARDINAL HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARDINAL HEALTH is operating at the current time. Most of CARDINAL HEALTH's value examination focuses on studying past and present price action to predict the probability of CARDINAL HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARDINAL HEALTH's price. Additionally, you may evaluate how the addition of CARDINAL HEALTH to your portfolios can decrease your overall portfolio volatility.